药物靶标作用关系预测是一种重要的辅助药物研发手段,而生物实验验证药物靶标作用关系耗钱耗时,因此,在数据库中查询验证预测的药物靶标作用关系是对预测方法的重要评价.基于KEGG,DrugBank,ChEMBL这3个数据库,利用爬虫获取信息的方式设...药物靶标作用关系预测是一种重要的辅助药物研发手段,而生物实验验证药物靶标作用关系耗钱耗时,因此,在数据库中查询验证预测的药物靶标作用关系是对预测方法的重要评价.基于KEGG,DrugBank,ChEMBL这3个数据库,利用爬虫获取信息的方式设计开发了药物靶标作用关系查询验证方法DTcheck(drug-target check),实现了对于提供KEGG DRUG ID及KEGG GENES ID的药物靶标对的高效查询验证功能,并利用DTcheck分别为Enzyme,IC(ion channel),GPCR(G-protein-coupled receptor),NR(nuclear receptor)四个标准数据集扩充新增药物靶标作用关系907,766,458,40对.此外,结合DTcheck查询验证,以BLM(bipartite local models)方法为例分析了预测结果的评价问题,结果表明,采用AUC(area under curve)值评价药物靶标作用关系预测方法没有Top N 评价合理,且AUC值低的BLMd方法在预测新的药物靶标作用关系时优于AUC值高的BLMmax方法.展开更多
药物-靶标作用关系预测在药物研发以及药物重定位中扮演着重要角色,但现有的机器学习方法在正负样本高度不平衡的数据上仍存在预测能力不足的问题。为此,提出一种基于图卷积神经网络的药物靶标作用关系预测方法。该方法首先构造一个结...药物-靶标作用关系预测在药物研发以及药物重定位中扮演着重要角色,但现有的机器学习方法在正负样本高度不平衡的数据上仍存在预测能力不足的问题。为此,提出一种基于图卷积神经网络的药物靶标作用关系预测方法。该方法首先构造一个结合多种药物(靶标)相关信息的异质信息网络,然后采用图卷积神经网络在此异质信息网络上学习得到能精确表达每个节点拓扑特征及邻居特征信息的低维向量表征,最后利用这些向量信息通过向量空间投影预测节点间概率的评分。在DrugBank_FDA和Yammanishi_08数据集上进行的药物-靶标作用关系预测的对比实验中,所提方法的AUPR(Area Under the Precision-Recall Curve)值都优于其他4种方法,并且在较大型数据集上也有较好的表现。实验结果表明,所提方法提高了样本高度不平衡时的药物-靶标作用关系预测性能;同时在生物药物数据库上的实验也验证了所提方法所发现的未知药物-靶标作用关系的有效性。展开更多
In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In ...In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest （RF） and Support Vector Machine （SVM）. The erformance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of pre- diction for drug-target interactions, with a concordance of 82.83% , a sensitivity of 81.33% , and a specificity of 93.62% , respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.展开更多
文摘药物靶标作用关系预测是一种重要的辅助药物研发手段,而生物实验验证药物靶标作用关系耗钱耗时,因此,在数据库中查询验证预测的药物靶标作用关系是对预测方法的重要评价.基于KEGG,DrugBank,ChEMBL这3个数据库,利用爬虫获取信息的方式设计开发了药物靶标作用关系查询验证方法DTcheck(drug-target check),实现了对于提供KEGG DRUG ID及KEGG GENES ID的药物靶标对的高效查询验证功能,并利用DTcheck分别为Enzyme,IC(ion channel),GPCR(G-protein-coupled receptor),NR(nuclear receptor)四个标准数据集扩充新增药物靶标作用关系907,766,458,40对.此外,结合DTcheck查询验证,以BLM(bipartite local models)方法为例分析了预测结果的评价问题,结果表明,采用AUC(area under curve)值评价药物靶标作用关系预测方法没有Top N 评价合理,且AUC值低的BLMd方法在预测新的药物靶标作用关系时优于AUC值高的BLMmax方法.
文摘药物-靶标作用关系预测在药物研发以及药物重定位中扮演着重要角色,但现有的机器学习方法在正负样本高度不平衡的数据上仍存在预测能力不足的问题。为此,提出一种基于图卷积神经网络的药物靶标作用关系预测方法。该方法首先构造一个结合多种药物(靶标)相关信息的异质信息网络,然后采用图卷积神经网络在此异质信息网络上学习得到能精确表达每个节点拓扑特征及邻居特征信息的低维向量表征,最后利用这些向量信息通过向量空间投影预测节点间概率的评分。在DrugBank_FDA和Yammanishi_08数据集上进行的药物-靶标作用关系预测的对比实验中,所提方法的AUPR(Area Under the Precision-Recall Curve)值都优于其他4种方法,并且在较大型数据集上也有较好的表现。实验结果表明,所提方法提高了样本高度不平衡时的药物-靶标作用关系预测性能;同时在生物药物数据库上的实验也验证了所提方法所发现的未知药物-靶标作用关系的有效性。
文摘In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest （RF） and Support Vector Machine （SVM）. The erformance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of pre- diction for drug-target interactions, with a concordance of 82.83% , a sensitivity of 81.33% , and a specificity of 93.62% , respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.
